APPROPRIATE USE OF CA125 IN MONITORING OF OVARIAN CANCER- ADVANTAGE OR DISADVANTAGE FOR AN INDIVIDUAL PATIENT

被引：0
|
作者：
Zwirner, M. [1 ]
Korte, K. [1 ]
机构：
[1] Univ Tubingen, Frauenklin, D-72076 Tubingen, Germany
来源：
ANTICANCER RESEARCH | 2014年 / 34卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
108
引用
收藏
页码：6856 / 6856
页数：1
相关论文
共 50 条
  • [1] CA125 in ovarian cancer
    Scholler, Nathalie
    Urban, Nicole
    BIOMARKERS IN MEDICINE, 2007, 1 (04) : 513 - 523
  • [2] Monitoring Ovarian Cancer: CA125 Trial Stirs Controversy
    Chitale, Radha
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (18) : 1233 - 1233
  • [3] IMMUNOASSAY OF CA125 IN OVARIAN-CANCER - A COMPARISON OF 3 ASSAYS FOR USE IN DIAGNOSIS AND MONITORING
    FISKEN, J
    LEONARD, RCF
    ROULSTON, JE
    DISEASE MARKERS, 1989, 7 (01) : 61 - 67
  • [4] CA125 Immune Complexes in Ovarian Cancer Patients with Low CA125 Concentrations
    Cramer, Daniel W.
    O'Rourke, Dennis J.
    Vitonis, Allison F.
    Matulonis, Ursula A.
    DiJohn-son, Daniel A.
    Sluss, Patrick M.
    Crum, Christopher P.
    Liu, Brian C. -S.
    CLINICAL CHEMISTRY, 2010, 56 (12) : 1889 - 1892
  • [5] Ovarian cancer: the duplicity of CA125 measurement
    Amer K. Karam
    Beth Y. Karlan
    Nature Reviews Clinical Oncology, 2010, 7 : 335 - 339
  • [6] Ovarian cancer: the duplicity of CA125 measurement
    Karam, Amer K.
    Karlan, Beth Y.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2010, 7 (06) : 335 - 339
  • [7] Tumor marker CA125 in ovarian cancer
    Tuxen, MK
    JOURNAL OF TUMOR MARKER ONCOLOGY, 2001, 16 (01): : 49 - 68
  • [8] CA125 and Ovarian Cancer: A Comprehensive Review
    Charkhchi, Parsa
    Cybulski, Cezary
    Gronwald, Jacek
    Wong, Fabian Oliver
    Narod, Steven A.
    Akbari, Mohammad R.
    CANCERS, 2020, 12 (12) : 1 - 29
  • [9] IMMUNORADIOMETRIC ASSAY FOR CA125 IN MONITORING THE COURSE OF EPITHELIAL OVARIAN-CANCER
    TOMMASI, M
    CAPPELLI, G
    FANTAPPIE, B
    CEFARATTI, C
    BONAZZA, M
    BRANCONI, F
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1986, 30 (01): : 45 - 50
  • [10] Is CA125 useful in monitoring patients with platinum-resistant ovarian cancer?
    Rustin, G. J. S.
    Hall, M. R.
    ANNALS OF ONCOLOGY, 2016, 27 (08) : 1365 - 1366
12345